Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short course chemotherapy for pulmonary tuberculosis.

L P Ormerod1, O R McCarthy, R M Rudd

  • 1Newham Chest Clinic, London, U.K.

Respiratory Medicine
|July 1, 1991
PubMed
Summary

A standard 6-month unsupervised tuberculosis treatment regimen showed a 4.59% relapse rate. This therapy, using rifampicin and isoniazid with pyrazinamide, offers satisfactory results in routine clinical practice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
Same author

The outcome of a cohort of tuberculin-positive predominantly South Asian new entrants aged 16-34 to the UK: Blackburn 1989-2001.

Journal of public health (Oxford, England)·2013
Same author

British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.

HIV medicine·2011
Same author

Molecular epidemiology of Mycobacterium tuberculosis in East Lancashire 2001-2009.

Thorax·2011
Same author

Management of peripheral lymph node tuberculosis in routine practice: an unselected 10-year cohort.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2011
Same author

Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children.

Archives of disease in childhood·2010

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Tuberculosis (TB) remains a significant global health challenge.
  • Effective and accessible treatment regimens are crucial for TB control.
  • Unsupervised therapy presents unique challenges and requires evaluation.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of a standard 6-month unsupervised treatment regimen for culture-positive pulmonary tuberculosis.
  • To determine the relapse rate associated with this specific therapeutic approach.

Main Methods:

  • A retrospective survey was conducted on patients with culture-positive pulmonary tuberculosis.
  • The study analyzed data from 164 patients who initiated a 6-month regimen of daily rifampicin and isoniazid, with pyrazinamide for the first 8 weeks.

Related Experiment Videos

  • Treatment completion and relapse data were collected and analyzed.

    • Main Results:

    • Out of 164 patients, 110 (67%) completed the planned therapy.
    • Five relapses were recorded, with three patients admitting significant non-compliance.
    • The overall relapse rate was 4.59% (95% confidence interval, 1.49-10.7).

    Conclusions:

    • The standard 6-month unsupervised treatment regimen for pulmonary tuberculosis yields satisfactory results in routine practice.
    • Adherence to therapy is a critical factor influencing treatment outcomes.
    • Further research may explore strategies to improve compliance in unsupervised settings.